AstraZeneca, Daiichi Sankyo, Summit Therapeutics to test cancer drug combo
AstraZeneca and Daiichi Sankyo are collaborating with Summit Therapeutics to test their cancer drug, Datroway, in combination with Summit's ivonescimab. The combination will be tested across multiple tumor types, including lung and breast cancers.